Education and Training
Dr Ian Geh graduated from the University College Hospital (UCH), University of London in 1988. Following his house officer posts at UCH and Middlesex Hospitals, he completed his Senior House Officer training in General Medicine at St Bartholomew’s and Homerton Hospitals. He then undertook registrar training in Clinical Oncology at Middlesex, Royal Free, Mount Vernon, Hammersmith and Charing Cross Hospitals. In 1998 he won the British Oncological Association Young Investigator’s Award for a project he completed on chemoradiotherapy treatment of rectal cancers.
Professional Memberships
Dr Ian Geh is a Council Member of the Association of Coloproctology of Great Britain and Ireland (ACPGBI).
Current Position
Dr Ian Geh was appointed as Consultant Clinical Oncologist at the Queen Elizabeth and at the Heartlands Hospitals, Birmingham in 1999. He specializes in the treatment of bowel (gastrointestinal or GI) cancers and is a recognized opinion leader in the management of rectal, anal, colon and oesophageal cancers and gastrointestinal stromal tumours (GISTs). He is also an Honorary Senior Lecturer at the University of Birmingham.
Management and Teaching Responsibilities
He is a co-author of the ACPGBI National Guidelines in the Management of Colorectal Cancer (2006) and Guidelines in the Management of GISTs (2009). He is the Lead Oncologist for the Pan-Birmingham Cancer Network Lower GI site-specific group.
Dr Ian Geh is a Royal College Tutor and educational supervisor to the specialty registrars in clinical oncology on the West Midlands training scheme. He sits on the Specialty Training Board of the Royal College of Radiologists. He was external examiner to the University of Malaya Masters in Clinical Oncology programme between 2006-2009.
Research and Publications
Dr Ian Geh has a high national profile in his research in the treatment of gastrointestinal cancers. He has published extensively in the medical literature and lectures regularly at National and International Conferences. He is a Member of the National Cancer Research Institute (NCRI) Upper GI Clinical Trials Group. He is co-investigator of the SCOPE-1 trial for oesophageal cancer and the TREC trial for early rectal cancer. To view Dr Ian Geh's published studies please click here.
